TRAF2 and gastric cancer: Thus, these results suggest that DR5‐Cbl‐b/c‐Cbl‐TRAF2 complex is present in TRAIL‐resistant gastric cancer cells and Cbl‐b and c‐Cbl are the critical adaptors linking DR5 and TRAF2.